Grants per year
Personal profile
Research Interests
I am an Assistant Professor of Urology at the Northwestern University Feinberg School of Medicine, as well as Section Chief of Robotic Surgery at the Jesse Brown VA Medical Center. I received his MD and PhD degrees from Northwestern University in 2005, completed my urology residency at Northwestern University in 2011, and a urologic oncology fellowship at Memorial Sloan-Kettering Cancer in 2012. My clinical efforts focus on minimally invasive and open urologic oncology with a particular interest in bladder and prostate cancer. My research interests focus on both the epigenetics and genetic mutations associated with cancer biology. Specifically,I am studying how chromatin remodeling genes play a role in bladder cancer. In addition, I am studying the “driver” mutations found in bladder cancer. In the future, I hope to develop novel systemic and intravesical therapies to improve survival of patients with bladder cancer.
Certifications and Licenses
| Urology |
Training Experience
| 2006 | Internship, Northwestern University, Feinberg School of Medicine |
| 2011 | Residency, Northwestern University, Feinberg School of Medicine |
| 2012 | Fellowship, Memorial Sloan-Kettering Cancer Center |
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, Northwestern University Feinberg School of Medicine
… → 2005
Cell Biology, PhD, Northwestern University Feinberg School of Medicine
… → 2003
Research interests
- Big Data
- Bioinformatics
- Bladder Cancer
- Bladder and Urinary Tract
- Genetics
- Immunogenetics
- Immunology
- Oncology
- Robotic Surgery
- Translational Research
- Urology
Fingerprint
Dive into the research topics where Joshua J Meeks is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #42756493BLC2003: A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGF
Janssen Research & Development, LLC
8/6/21 → 9/11/26
Project: Research project
-
An Evaluation of Immune Infiltration of Bladder Cancer After Transurethral Resection of a Bladder Tumor (TURBT)
4/12/21 → 4/12/23
Project: Research project
-
-
Prot #QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302)
Pharmaceutical Research Associates, Inc., QED Therapeutics, Inc.
9/15/20 → 9/15/23
Project: Research project
-
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
Lobo, N., Brooks, N. A., Zlotta, A. R., Cirillo, J. D., Boorjian, S., Black, P. C., Meeks, J. J., Bivalacqua, T. J., Gontero, P., Steinberg, G. D., McConkey, D., Babjuk, M., Alfred Witjes, J. & Kamat, A. M., 2021, (Accepted/In press) In: Nature Reviews Urology.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Lindskrog, S. V., Prip, F., Lamy, P., Taber, A., Groeneveld, C. S., Birkenkamp-Demtröder, K., Jensen, J. B., Strandgaard, T., Nordentoft, I., Christensen, E., Sokac, M., Birkbak, N. J., Maretty, L., Hermann, G. G., Petersen, A. C., Weyerer, V., Grimm, M. O., Horstmann, M., Sjödahl, G., Höglund, M. & 27 others, , Dec 2021, In: Nature communications. 12, 1, 2301.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Editorial Comment
Meeks, J. J., Jan 1 2021, In: The Journal of urology. 205, 1, p. 107 1 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Evaluating Patient-Defined Priorities for Female Patients with Bladder Cancer
Vo, A. X., Keeter, M. K., Tuchman, E. S., Meeks, J. J. & Morgans, A. K., 2021, In: Bladder Cancer. 7, 1, p. 53-60 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Rapamycin enhances BCG-specific 3δT cells during intravesical BCG therapy for non-muscle invasive bladder cancer: A randomized, double-blind study
Ji, N., Mukherjee, N., Reyes, R. M., Gelfond, J., Javors, M., Meeks, J. J., McConkey, D. J., Shu, Z. J., Ramamurthy, C., Dennett, R., Curiel, T. J. & Svatek, R. S., Mar 2 2021, In: Journal for immunotherapy of cancer. 9, 3, e001941.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations